The purpose of the present study was to investigate and compare the effects of two ruthenium complexes with trifl uoperazine on acethylcholinesterase enzyme activity and lactate dehydrogenase levels in vivo under physiological conditions in rats blood. Complexes 1 and 2 showed positive effects on acethylcholinesterase at all doses and did not disturb its normal activity. Total LDH activity was inhibited in the presence of both complexes, but Ru(II) complexes showed different effects on the activity of LDH isoenzymes. The activities of LDH 1 and LDH 2 isoenzymes were decreased in all applied doses of the complex 2, while the activity of LDH 2 reduced using complex 1 in the same doses. Results of the present study suggest the neuro-and cardio protective potential of oral administration of complexes 1 and 2, as non-toxic compounds under physiological conditions. These protective effects are the result of their potent antioxidant activity.
INTRODUCTION
Metal complexes of ruthenium have been for more than twenty years in the focus of many researches in chemistry [1] [2] [3] [4] as well as in medicine [5, 6] . Their properties can be altered by the choice of ligands, which means that complexes potentially have multiple applications. Ruthenium complexes show an antimicrobial activity [5, 7] but their most interesting activity is on tumor cells [8] [9] [10] with developed resistance to the usual medicinal treatment, including cisplatin. The advantage of ruthenium complexes is their relatively low toxicity [6, 11] , lower than cisplatin, which can partly be explained by its reduced reactivity to DNA in intact cells. Many biological properties have been attributed to ruthenium complexes including antioxidant activity [12, 13] and cytotoxicity [3, 9, 10] . Anticancer activities of Ru(II)-DMSO complexes are known for many years and some of them are in intensively clinical trials [14, 15] , while Ru(II)-arene complexes have been also widely studied as anticancerogenic compounds [3, 16] . Previous investigations of enzyme activities of ruthenium complexes demonstrated a slight induction of superoxide dismutase (SOD) and catalase (CAT) in the rat liver tissue [17] , but also an inhibition of succinate dehydrogenase (SDH) and cytochrome oxidase (COX) activities in the brain, heart, skeletal muscle, liver and kidney of rats [18] . Ruthenium(II) and ruthenium(III) complexes exhibit antioxidative enzyme activities (SOD, CAT) and might be responsible for complex-induced cytotoxicity [19] . Expression of lactate dehydrogenase (LDH) isoenzymes and tumors was investigated [20] and it was found that inhibition of LDH can be considered one of the ways to control tumor growth [21] . Ruthenium complexes have a good cytotoxic effect and their possible applications as non-competitive inhibitors of LDH were reported [22, 23] . Ru(II) complexes can decrease total levels of serum LDH and LDH 4 in tumor cells, as well as increase serum glutamate oxaloacetate transaminase (SGOT) activity, without toxic effects on the liver [23] . A relationship between the increase of acethylcholinesterase and apoptosis of tumor cells was also reported [24, 25] . Acetylcholinesterase (AChE) is a hydrolase in the nervous system that plays a key role in cholinergic transmission by catalyzing the rapid hydrolysis of the neurotransmitter acetylcholine (ACh) [26] . This enzyme was identifi ed in the amyloid plaques found in Alzheimer's disease and the isoforms of AChE have different effects on the extent of plaque development [27] .
Among the numerous drugs reported, phenothiazine and its N-alkyl derivatives are specifi c. Phenothiazines are sulpfur-and nitrogen-containing tricyclic aromatic compounds, famous as dyes in the middle of the nineteen century, after what they found their application in pharmacy and medicine as antipsychotic, antihistaminic, antiemetic and analgetic drugs [5, 28] . In the literature are described few mononuclear complexes with phenothiazines as ligands coordinated in a monodentate fashion through heterocyclic sulfur [29] [30] [31] or through heterocyclic nitrogen [32] . Despite the description of synthetic derivatives with transition metals [33, 34] , only partial biological activities of these compounds were tested.
New Ru(II)-DMSO and Ru(II)-p-cymene complexes with N-alkylphenothiazines were previously synthesized and characterized by elemental analysis and spectroscopic methods (FT-IR, UV-Vis, 1 H and 13 C NMR) [35, 36] . These complexes showed effects on antioxidative enzymes, as well as malondyaldehyde and nitrite levels in rats blood. Therefore, in vitro cytotoxic activity of complexes was assayed in four human carcinoma cell lines MCF-7, MDA-MB-453 (breast carcinoma), SW-480 (colon carcinoma) and IM9 (myeloma multiple cells).
In continuation of our previous research [35, 36] , the aim of the present study was to investigate the effect of two ruthenium complexes with trifl uoperazine, previously prepared and characterized in our laboratory (Scheme 1), on acethylcholinesterase enzyme activity in rats blood as well as their ability to infl uence LDH levels in vivo under physiological conditions.
MATERIALS AND METHODS

Chemicals
All reagents and chemicals were purchased from commercial sources. Enzyme activities were measured on CECIL CE 2021 UV/VIS spectrophotometer, while electrophoresis was performed on a vertical device Mini Ve Hoffer, LKB 2117, Bromma, Uppsala, Sweden. The band intensities of the isoenzymes of LDH were estimated using Scion Image Beta 4.02 software for Windows.
The complex (TF.2H)Ru(DMSO) 3 Cl 3 Cl·0.5C 2 H 5 OH (1) was prepared by the reaction of complex RuCl 2 (DMSO) 4  and trifl uoperazine dihydrochloride (TF.2HCl) in absolute ethanol [35] . In the reaction the starting complex RuCl 2 ( 6 -p-cymene) 2 with TF.2HCl in 2-propanol as solvent, complex 2 (TF.2H)RuCl 3 ( 6 -p-cymene) Cl·0.5C 3 H 7 OH·0.5H 2 O was synthesized [36] . Both complexes were characterized by elemental analysis, spectroscopic methods and x-ray diffraction as previously described [35, 36] .
Biological assays
The experiments were carried out on adult male Wistar rats (200-300 g) housed in stainless steel cages with wired fl oors and with free access to food and water, in a room under controlled conditions (12 h light-dark cycle, temperature 22 ± 2 °C). Rats were randomly assigned to an experimental or to the control group. All experiments were done according to our institutional guidelines for animal research and principles of the European Convention for the Protection of Vertebrate Animals Used for Rats were divided into seven groups of eight animals each: the control (group I), and three separate groups for each compound treated i.p. with complexes dissolved in water, at doses of 0.4 μmol kg -1 bw (group II), 4.5 μmol kg -1 bw (group III) and 90.4 μmol kg -1 bw (group IV). Blood samples (6-8 ml) were obtained via aorta abdominalis puncture (from all rats, including the control group, 24 h after treatment) and collected in tubes containing sodium-citrate (3.8% w/v) as anticoagulant. Erythrocytes and plasma were separated by centrifugation (3000 rpm), then the erythrocytes were washed in saline solution three times, and the enzymes activities were determined immediately.
Determination of AChE activity in erythrocytes
AChE activity was determined as described at an earlier date [37] . The principle of the method is the measurement of the production rate of thiocholine as acetylthiocholine is hydrolyzed. This is accomplished by the continuous reaction of the thiol with 5,5'-dithiobis-2-nitrobenzoate ion to produce the yellow anion of 5-thio-2-nitrobenzoic acid. The rate of color production is measured at 412 nm. Activity was expressed as U/g Hb.
Determination of LDH activity in plasma
The total LDH activity in plasma was determined spectrophotometically according to the method of McQueen [38] . In the reaction between sodium piruvate and NADH at pH 7.2 lactate is formed, which reacts with the enzyme from the plasma.The activity of LDH is determined by the decrease in absorbance at 340 nm and expressed as U/ mg proteins.
LDH isoenzymes (LDH [1] [2] [3] [4] [5] ) were detected by vertical electrophoresis on non-denaturing 7% PAGE using a Tris-glycine buffer, following the methods described [39] . The isoenzymes bands were detected using lithium lactate as a substrate in the presence of cofactors NADH and tetrazolium blue. The color intensity of each isoenzyme strip was measured by densitometry. The density of each band was estimated with respect in percent to the total area. The band intensities of the LDH isoenzymes were estimated using Scion Image Beta 4.02 software [40] .
Statistical analysis
Data are expressed as the means ± SD. Statistical signifi cance was tested by one-way Anova followed by Dunnett's t-test. The minimum level of statistical signifi cance was set to p < 0.05.
RESULTS
The AChE activity was signifi cantly increased (p < 0.01) by using 4.5 and 90.4 μmol kg -1 bw of complex 1 as present in Fig. 1a . The effect of complex 2 on AChE activity in erythrocytes was different and signifi cantly higher in all applied doses compared to the control group (Fig. 1b) . Therefore, almost the same effect was noticed using lower doses of complex 2 (0.4 and 4.5 μmol kg -1 bw). A signifi cant increase of AChE activity with 90.4 μmol kg -1 bw complex 2 was also observed.
The present study demonstrated that the ruthenium(II) complexes inhibited total LDH activity in all applied doses compared to the control group, however the difference was not statistically signifi cant (p < 0.05) (Fig. 2) .
The effects of ruthenium(II) complexes on the activity of LDH isoenzymes are here presented (Table 1 and 2). Complex 1 reduced the activity of LDH 2 isoenzyme at all applied doses, while it signifi cantly increased (p < 0.01) LDH 1 isoenzyme activity in The infl uence of complex 2 on LDH activity is given in Table 2 . Complex 2 caused a signifi cant decline in the activity of LDH 2 in all treated groups with signifi cant inhibition (p < 0.05) at doses of 4.5 μmol kg -1 (group III) and 90.4 μmol kg -1 (group IV) ( Table 2) . A signifi cant increase (p < 0.05) was also observed in the activity of LDH 4 •-) and hydrogen peroxide (H 2 O 2 ) are constantly generated in aerobic organisms. Their low levels are vital for a number of cell signaling events and they are essential for proper cell function. Otherwise, high concentrations of ROS result in oxidative stress and as a result damage the biological macromolecules. To protect against oxidative damage, organisms developed a variety of antioxidant defenses that include specialized antioxidant enzymes as superoxide dismutase (SOD), glutathione peroxidase (GPX) and catalase (CAT). Ruthenium(II) complexes showed effects on the activity of antioxidative blood enzymes (SOD and CAT) in rats treated i.p. with complexes at three different doses: 0.4, 4.5 and 90.4 μmol kg -1 bw [35, 36] .
The biological effect of these Ru(II) complexes were investigated. AChE activity as a parameter of their infl uence on brain function was tested. Acetylcholinesterase is an enzyme present in the nervous tissue, muscle and erythrocytes that catalyzes the hydrolysis of acetylcholine to choline and acetic acid. This enzyme is present throughout the body, but the activity of AChE is higher in motor than sensor neurons. Inhibition of AChE leads to accumulation of acetylcholine in the synapses, signaling is interrupted, which results in dysfunctioning nerve impulses. Many diseases are connected to the inhibition of AChE, as myasthenia gravis, Parkinson's and Alzheimer's diseases [41] .
Both complexes showed a strong positive effect at the highest dose (4.5 and 90.4 μmol kg -1 bw), while applied in 4.5 μmol kg -1 bw complex 1 increased AChE activity more than complex 2. Conversely, a better effect on AChE complex 2 was shown at lower doses compared to complex 1. As it is well known, the activity of AChE is in correlation with apoptosis of cancer cells and these results agree with cytotoxic effects of complexes 1 and 2 [35, 36] .
The disturbance of the cell membrane integrity causes an increase in the extracellular concentration of big macromolecules, such as LDH. Lactate dehydrogenase is a tetrameric cytoplasmatic enzyme present in almost all major organs. Its role in the metabolism is to catalyse the oxidation of L-lactate to pyruvate as the fi nal step in the metabolic chain of anaerobic glycolysis. Four peptide chains form two types of lactate dehydrogenase: heart (H) subunit or muscle (M) subunit, which are so named because of their predominance in the respective tissues. LDH has fi ve different isoenzyme forms which catalyze the same biochemical reaction but differ in their molecular structure, and organ specifi city. The isoenzymes are separable by electrophoresis. The subunit compositions of fi ve isoenzymes, in order of decreasing anodal mobility in an alkaline medium are: LDH 1 and LDH 2 (found primarily in the heart and red blood cells), LDH 3 (kidneys and brain), LDH 4 (lung and spleen) and LDH 5 (dominantly in the liver and muscle) [42] . Determination of the isoenzyme forms of this enzyme enables us to defi ne the type and the level of cell damage in some tissues [43] .
Total LDH activities were reduced by both ruthenium complexes, compared to the activity of this enzyme in the control group. Complex 1 slightly decreased total LDH activity with increasing applied doses. In the case of complex 2 the biological effect was the opposite. Complex 2 caused an increase of total enzyme activity from 0.4 to 90.4 μmol kg -1 bw, but without a signifi cant difference (p < 0.05).
Complex 1 decreases the activity of LDH 2 isoenzyme in all applied doses, while the activities of the LDH 1 and LDH 4 are increased if complex 1 is applied at a dose of 4.5 μmol kg -1 bw. These results are in agreement with previous studies [22] and show a strong inhibition of LDH isoenzymes induced by Ru(II)-DMSO complex. Both complexes show a signifi cant increase in the activity of LDH 5 in the highest applied dose, which may suggest potential hepatotoxic effects, but at the same time these doses of complexes signifi cantly reduce activity of LDH 2 primarily from red blood cells. The activity of LDH 1 isoenzyme is decreased at all applied doses of complex 2, while the effect of this complex on LDH 4 and LDH 5 shows an increase of their activities (Fig. 3) . This study clearly demonstrates that LDH isoenzymes are sensitive to all applied doses of the investigated Ru(II)complex.
An important effect of LDH activity inhibition is the decrease anaerobic glycolysis in cells which is crucial for the growth of tumor cells. Earlier researches [23, 44] have shown that metal complexes can bind to LDH and thus reduce its activity or change the conformation of the enzyme. Ru(II) complexes 1 and 2 reduce total LDH, probably in a similar fashion, which can be connected with previously proved cytotoxicity [35, 36] .
In summary, biological assays of Ru(II) complexes with Nalkylphenothiazine ligands provide clear evidence that complex 1, under physiological conditions can increase the activity of AChE at higher doses, while complex 2 has a positive infl uence at all applied doses. These results suggest that the complexes do not lead to enhanced production of acetylcholine and thus do not cause neuromuscular diseases.
Results of LDH isoenzymes activities measuring exhibit different sensitivity, depending on the applied concentration of the complexes 1 and 2, but also a positive effect on the heart muscle due to the decreased activity of isoenzymes LDH 2 with increasing concentration of these complexes, compared to the control group. Also, complex 1 does not damage the brain tissue (LDH 3 is not signifi cant increased, while AChE activity signifi cantly increased), while both complexes show positive effects on liver in lower doses (LDH 5 ).
Results of the present study suggest the neuro-and cardioprotective potential of orally administered complexes 1 and 2, as non-toxic compounds under physiological conditions, induced through its potent antioxidant activity. This investigation confi rms a great potential of Ru(II)-cymene complexes as pharmacological drugs and potential biological compounds with promising applications. The whole mechanism of infl uence of Ru(II) complexes on cancer cells via anaerobic glycolysis will be the subject of our future research.
